Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system

Cost-effectiveness analysis of whole-mount pathology processing for patients with early breast cancer undergoing breast conservation

(2016) N.J. Look Hong et al.   Current Oncology

The use of cannabinoids as anticancer agents

(2016) Guillermo Velasco et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Anandamide drives cell cycle progression through CB1 receptors in a rat model of synchronized liver regeneration

(2015) Simona Pisanti et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Cannabinoids as therapeutic agents in cancer: current status and future implications

(2015) Bandana Chakravarti et al.   Oncotarget

The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription

(2012) RB Laprairie et al.   BRITISH JOURNAL OF PHARMACOLOGY

A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma

(2011) S. Torres et al.   MOLECULAR CANCER THERAPEUTICS

Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology Group

(2011) Jeffrey H. Wisoff et al.   NEUROSURGERY

Long-term Follow-up of Pediatric Benign Cerebellar Astrocytomas

(2011) Hideki Ogiwara et al.   NEUROSURGERY

Impact of chemotherapy on disseminated low-grade glioma in children and adolescents: Report from the HIT-LGG 1996 trial

(2011) Stephan von Hornstein et al.   PEDIATRIC BLOOD & CANCER

Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas

(2010) Katrin Scheinemann et al.   PEDIATRIC BLOOD & CANCER

Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis

(2009) Daniel K. Nomura et al.   CELL

Cannabinoids Inhibit Glioma Cell Invasion by Down-regulating Matrix Metalloproteinase-2 Expression

(2008) C. Blazquez et al.   CANCER RESEARCH